Therapeutic strategies targeting FOXO transcription factors. (2021)
Attributed to:
Targeting the FOXM1 signature for early diagnosis and treatment in cholangiocarcinoma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41573-020-0088-2
PubMed Identifier: 33173189
Publication URI: http://europepmc.org/abstract/MED/33173189
Type: Journal Article/Review
Volume: 20
Parent Publication: Nature reviews. Drug discovery
Issue: 1
ISSN: 1474-1776